TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

Clinical trial NCT00896051 · COMPLETED

Trial details

NCT number: NCT00896051
Sponsor: Janssen R&D Ireland
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infections Acquired Immunodeficiency Syndrome

Start date: 2009-08-01
Primary completion: 2012-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.